Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
284.2 SEK | +1.00% |
|
+2.82% | +6.44% |
06-19 | Sobi Wins EU Approval for Hemophilia A Drug Altuvoct | MT |
06-19 | European Commission Grants Sobi® Marketing Authorisation for Altuvoct? for Treatment of Haemophilia A | CI |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB